Key Details
Price
$391.00Last Dividend
$0.84Annual ROE
15.26%Beta
0.62Events Calendar
Next earnings date:
Apr 30, 2025Recent quarterly earnings:
Jan 28, 2025Recent annual earnings:
Jan 28, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
Dec 31, 2024Next split:
N/ARecent split:
May 17, 2004Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Stryker Corporation (SYK), a company that makes medical devices, gains advantages from an increase in procedures, sales, and acquisitions.
On Wednesday, Wall Street analysts updated their ratings for Stryker Corp (SYK) following the company's fourth-quarter results.
On Wednesday, Wall Street analysts updated their ratings for Stryker Corp (SYK) following the company's fourth-quarter results.
SYK's results for the fourth quarter show good performance in different areas and an increase in operating margin.
While the revenue and earnings per share (EPS) for Stryker (SYK) provide insight into its performance for the quarter ending December 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.
Stryker (SYK) reported quarterly earnings of $4.01 per share, which is higher than the Zacks Consensus Estimate of $3.87 per share. This is an increase compared to earnings of $3.46 per share from the same period last year.
On Tuesday, Stryker exceeded Wall Street's predictions for its fourth-quarter profits and projected earnings for 2025 that are significantly higher than expected, thanks to high demand for its medical and surgical products.
Portage, Michigan, January 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) has announced its operating results for the fourth quarter and the entire year of 2024.
SYK's results for the fourth quarter of 2024 are anticipated to show good performance in different areas. Nevertheless, increasing costs are probably still affecting profit margins.
Stryker Corporation is a well-respected and innovative medical device company that has shown strong growth in revenue, earnings, and free cash flow, thanks to its focus on research and development as well as mergers and acquisitions. Although its shares are currently priced high with a PEG ratio of about 3, the company's steady performance and leadership in the market support this higher valuation. Additionally, Stryker's strong company culture, high return on invested capital, and significant insider ownership suggest it has a lasting competitive edge and a promising future.
FAQ
- What is the primary business of Stryker?
- What is the ticker symbol for Stryker?
- Does Stryker pay dividends?
- What sector is Stryker in?
- What industry is Stryker in?
- What country is Stryker based in?
- When did Stryker go public?
- Is Stryker in the S&P 500?
- Is Stryker in the NASDAQ 100?
- Is Stryker in the Dow Jones?
- When was Stryker's last earnings report?
- When does Stryker report earnings?
- Should I buy Stryker stock now?